Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DB25FX7X7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,524
Award facts
- Contract value 100% obligated
- $15,524.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order valued at $15,524.40 for 200-unit vials of Botox on September 2, 2025. This firm fixed-price delivery order will be performed in Park Ridge, Illinois and carries an ultimate completion date of September 23, 2025. No set-aside designation was applied to this award, indicating the contractor competed on an unrestricted basis. This delivery order is issued under DMS Pharmaceutical Group's existing $499.999 billion Indefinite Delivery Contract with the DLA under the SPE2DB program, which remains valid through November 2026 and enables the agency to procure a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities worldwide.
Botox delivery orders such as this represent routine pharmaceutical supply requirements for military medical installations, where the product is used for both therapeutic and cosmetic purposes within military health services. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status and extensive portfolio of branded and generic prescription drugs, biologics, and medical consumables. The company's consistent award history with the DLA demonstrates its capability to meet federal procurement standards and support the medical supply needs of military healthcare systems across the nation.
Quick answers
Who was awarded contract SPE2DB25FX7X7?
SPE2DB25FX7X7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 2, 2025.
How much is contract SPE2DB25FX7X7 worth?
The government has obligated $15,524 on SPE2DB25FX7X7.
Is contract SPE2DB25FX7X7 an order under another contract?
Yes. SPE2DB25FX7X7 is a delivery order under SPE2DB20D9354, an indefinite delivery contract.
Was contract SPE2DB25FX7X7 competed?
The extent of competition for SPE2DB25FX7X7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award